AR043579A1 - Procedimiento para la preparacion de ciclesonida cristalina con un tamano definido de particulas - Google Patents
Procedimiento para la preparacion de ciclesonida cristalina con un tamano definido de particulasInfo
- Publication number
- AR043579A1 AR043579A1 ARP040100815A ARP040100815A AR043579A1 AR 043579 A1 AR043579 A1 AR 043579A1 AR P040100815 A ARP040100815 A AR P040100815A AR P040100815 A ARP040100815 A AR P040100815A AR 043579 A1 AR043579 A1 AR 043579A1
- Authority
- AR
- Argentina
- Prior art keywords
- crystalline
- preparation
- compound
- formula
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F21/00—Dissolving
Abstract
La ciclesonida cristalina obtenida de acuerdo con el nuevo procedimiento presenta ventajosas propiedades aerodinámicas, y se puede transformar ulteriormente, sin ninguna micronización adicional por medios mecánicos, en formulaciones farmacéuticas inhalables o que se administran por vía nasal. Reivindicación 1: Procedimiento para la preparación de un compuesto de la fórmula (1), en forma cristalina, con un tamano definido de partículas, que comprende las etapas de: a) preparación de una solución del compuesto de la fórmula (1) en un apropiado disolvente orgánico, miscible con agua; b) adición de la solución obtenida de acuerdo con a) al agua, y c) aislamiento del material precipitado formado del compuesto de fórmula (1).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03007007 | 2003-03-27 | ||
DE10314097 | 2003-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043579A1 true AR043579A1 (es) | 2005-08-03 |
Family
ID=33099298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040100815A AR043579A1 (es) | 2003-03-27 | 2004-03-12 | Procedimiento para la preparacion de ciclesonida cristalina con un tamano definido de particulas |
Country Status (28)
Country | Link |
---|---|
US (1) | US9422327B2 (es) |
EP (1) | EP1611150B1 (es) |
JP (1) | JP4746535B2 (es) |
KR (1) | KR101102709B1 (es) |
AR (1) | AR043579A1 (es) |
AT (1) | ATE546459T1 (es) |
AU (1) | AU2004224092B2 (es) |
BR (1) | BRPI0408569B1 (es) |
CA (1) | CA2519752C (es) |
CL (1) | CL2004000636A1 (es) |
CY (1) | CY1112970T1 (es) |
DK (1) | DK1611150T3 (es) |
EA (1) | EA011157B1 (es) |
ES (1) | ES2382928T3 (es) |
HK (1) | HK1088905A1 (es) |
HR (1) | HRP20050917B1 (es) |
IL (1) | IL170746A (es) |
MX (1) | MXPA05010041A (es) |
MY (1) | MY143936A (es) |
NO (1) | NO331984B1 (es) |
NZ (1) | NZ542827A (es) |
PE (1) | PE20050388A1 (es) |
PL (1) | PL1611150T3 (es) |
PT (1) | PT1611150E (es) |
RS (1) | RS52549B (es) |
SI (1) | SI1611150T1 (es) |
TW (1) | TWI328589B (es) |
WO (1) | WO2004085460A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
US20070135398A1 (en) * | 2005-11-02 | 2007-06-14 | Pierluigi Rossetto | Process for the preparation of ciclesonide |
JP2009526068A (ja) * | 2006-02-08 | 2009-07-16 | シコール インコーポレイティド | シクレソニド結晶形 |
WO2008015696A2 (en) * | 2006-05-23 | 2008-02-07 | Cadila Healthcare Limited | Process for preparing ciclesonide |
WO2008062450A2 (en) * | 2006-09-18 | 2008-05-29 | Cadila Healthcare Limited | Crystalline polymorphs of ciclesonide |
WO2008035066A2 (en) * | 2006-09-19 | 2008-03-27 | Cipla Limited | Processes for the preparation of ciclesonide and its crystal form |
IT1397499B1 (it) * | 2009-01-09 | 2013-01-16 | Farmabios Spa | Processo per la preparazione di ciclesonide |
WO2009112557A2 (en) * | 2008-03-13 | 2009-09-17 | Farmabios S.P.A. | Process for the preparation of pregnane derivatives |
WO2010054158A2 (en) * | 2008-11-07 | 2010-05-14 | Auspex Pharmaceuticals, Inc. | Steroid modulators of glucocorticoid receptor |
US9109005B2 (en) | 2012-02-23 | 2015-08-18 | Boehringer Ingelheim International Gmbh | Method for manufacturing of ciclesonide |
WO2014007770A2 (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising corticosteroid and sorbitol |
US10111957B2 (en) | 2012-07-05 | 2018-10-30 | Arven Ilac Snayi ve Ticaret A.S. | Inhalation compositions comprising glucose anhydrous |
WO2014007781A2 (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions |
CR20180594A (es) | 2016-06-02 | 2019-07-29 | Abbvie Inc | Agonista del receptor de glucocorticoides e inmunoconjugados del mismo |
RU2020117698A (ru) | 2017-12-01 | 2022-01-04 | Эббви Инк. | Агонист глюкокортикоидного рецептора и его иммуноконъюгаты |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8328929D0 (en) * | 1983-10-29 | 1983-11-30 | Sterwin Ag | Steroid compounds |
JP2843857B2 (ja) | 1988-10-05 | 1999-01-06 | ファルマシア・アンド・アップジョン・カンパニー | 反溶剤への沈澱を介する微細分化固体結晶性粉末 |
EP0407028B2 (en) | 1989-05-31 | 1999-07-07 | FISONS plc | Medicament inhalation device and formulation |
GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
FR2668945B1 (fr) | 1990-11-12 | 1993-02-19 | Theramex | Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus. |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
GB9213874D0 (en) | 1992-06-30 | 1992-08-12 | Fisons Plc | Process to novel medicament form |
GB9306703D0 (en) | 1993-03-31 | 1993-05-26 | Fisons Plc | Inhalation device |
HU220868B1 (en) * | 1993-04-02 | 2002-06-29 | Byk Gulden Lomberg Chem Fab | New prednisolone derivative, process for its production, use of the same and pharmaceutical composition containing the same |
IL111194A (en) | 1993-10-08 | 1998-02-08 | Fisons Plc | Process for the production of drug patramulations |
ES2154725T3 (es) * | 1994-03-09 | 2001-04-16 | Byk Gulden Lomberg Chem Fab | Nuevos compuestos de sililo y su utilizacion. |
DE19541689A1 (de) | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Kombinationsarzneimittel |
DE19635498A1 (de) | 1996-09-03 | 1998-03-26 | Byk Gulden Lomberg Chem Fab | Verfahren zur Epimerenanreicherung |
US6120752A (en) * | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
GB9722285D0 (en) | 1997-10-23 | 1997-12-17 | Rhone Poulenc Rorer Ltd | Inhalation device |
US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
ES2234266T3 (es) * | 1998-07-24 | 2005-06-16 | Jago Research Ag | Formulaciones medicas para aerosoles. |
GB9828721D0 (en) * | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
DE50011218D1 (de) * | 1999-06-25 | 2005-10-27 | Cognis Ip Man Gmbh | Verwendung von nanoskaligen sterolen und sterolestern |
AR026073A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
AR026072A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa |
EA006231B1 (ru) * | 2000-11-10 | 2005-10-27 | Алтана Фарма Аг | Способ получения 16,17-[(циклогексилметилен)бис(окси)]-11,21-дигидроксипрегна-1,4-диен-3,20-диона или его 21-изобутирата транскетализацией |
-
2004
- 2004-02-13 MY MYPI20040475A patent/MY143936A/en unknown
- 2004-02-19 TW TW093104136A patent/TWI328589B/zh not_active IP Right Cessation
- 2004-03-12 AR ARP040100815A patent/AR043579A1/es unknown
- 2004-03-25 CL CL200400636A patent/CL2004000636A1/es unknown
- 2004-03-25 PE PE2004000317A patent/PE20050388A1/es not_active Application Discontinuation
- 2004-03-26 DK DK04723609.6T patent/DK1611150T3/da active
- 2004-03-26 PL PL04723609T patent/PL1611150T3/pl unknown
- 2004-03-26 JP JP2006505496A patent/JP4746535B2/ja not_active Expired - Lifetime
- 2004-03-26 SI SI200431866T patent/SI1611150T1/sl unknown
- 2004-03-26 NZ NZ542827A patent/NZ542827A/en unknown
- 2004-03-26 ES ES04723609T patent/ES2382928T3/es not_active Expired - Lifetime
- 2004-03-26 BR BRPI0408569-8A patent/BRPI0408569B1/pt active IP Right Grant
- 2004-03-26 MX MXPA05010041A patent/MXPA05010041A/es active IP Right Grant
- 2004-03-26 EP EP04723609A patent/EP1611150B1/en not_active Expired - Lifetime
- 2004-03-26 CA CA2519752A patent/CA2519752C/en not_active Expired - Fee Related
- 2004-03-26 EA EA200501391A patent/EA011157B1/ru not_active IP Right Cessation
- 2004-03-26 US US10/549,631 patent/US9422327B2/en active Active
- 2004-03-26 AT AT04723609T patent/ATE546459T1/de active
- 2004-03-26 KR KR1020057017580A patent/KR101102709B1/ko active IP Right Grant
- 2004-03-26 RS YU20050704A patent/RS52549B/en unknown
- 2004-03-26 WO PCT/EP2004/050373 patent/WO2004085460A1/en active Application Filing
- 2004-03-26 AU AU2004224092A patent/AU2004224092B2/en not_active Expired
- 2004-03-26 PT PT04723609T patent/PT1611150E/pt unknown
-
2005
- 2005-09-08 IL IL170746A patent/IL170746A/en active IP Right Grant
- 2005-10-19 HR HRP20050917AA patent/HRP20050917B1/hr not_active IP Right Cessation
- 2005-10-19 NO NO20054835A patent/NO331984B1/no unknown
-
2006
- 2006-08-21 HK HK06109236.9A patent/HK1088905A1/xx not_active IP Right Cessation
-
2012
- 2012-05-08 CY CY20121100425T patent/CY1112970T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR043579A1 (es) | Procedimiento para la preparacion de ciclesonida cristalina con un tamano definido de particulas | |
JP6375037B2 (ja) | 生薬等含有医薬組成物(肆) | |
CL2019000209A1 (es) | Formulación novedosa administrable por la vía oral. | |
UY39192A (es) | Dispersión sólida, proceso para prepararla y forma de dosificación farmacéutica suministrable por vía oral que la comprende | |
MX349533B (es) | Dispersiones solidas que contienen un agente inductor de apoptosis. | |
ATE522507T1 (de) | Montelukast in fester phase | |
AR007195A1 (es) | Forma farmaceutica de dosificacion, proceso para prepararla y uso de la misma para la preparacion de un medicamento para el tratamiento de infecciones virales | |
JP2008533007A5 (es) | ||
AR060974A1 (es) | Compuesto de 4-piridinona, su uso para la preparacion de un medicamento, composicion farmaceutica que lo comprende, proceso para su preparacion y proceso para la preparacion de un compuesto intermediario de utilidad en el anterior | |
WO2010144464A3 (en) | Solid dispersions containing an apoptosis-promoting agent | |
AR095159A2 (es) | Una composición farmacéutica en forma de cápsula para administración oral | |
AR029456A1 (es) | Forma triturada | |
SE0950390L (sv) | System och process för tillverkning av en lösning med suspenderade fasta ämnen och användningar därför | |
PE20061007A1 (es) | Proceso para elaborar lactosa utilizando tecnicas pre-clasificacion y formulaciones farmaceuticas formadas a partir de ella | |
JP2013523676A5 (es) | ||
NZ602441A (en) | A fast dissolving pharmaceutical composition | |
ECSP11011289A (es) | Formulaciones galénicas de compuestos orgánicos | |
CY1121145T1 (el) | Συστημα χορηγησης φαρμακων για χορηγηση μιας υδατοδιαλυτης, κατιοντικης και αμφιφιλης φαρμακευτικως ενεργης ουσιας | |
AR053899A1 (es) | Formulaciones que continen glimepirida y/o sus sales | |
RU2010153660A (ru) | Композиции для лечения заболеваний верхних дыхательных путей и симптомокомплекса гриппа | |
WO2009151498A3 (en) | Memantine formulations | |
CN103864642B (zh) | 大黄酸衍生物及其合成方法和用途 | |
CO6470840A2 (es) | Formas farmacéuticas solubles de la n, n´-diaminodifenilsulfona para uso óptimo en el tratamiento de diversas enfermedades | |
AR054092A1 (es) | Composicion de compuestos organicos | |
CL2007001713A1 (es) | Composicion farmaceutica oral en forma de suspension acuosa que comprende particulas del antihelmintico carbamato de bencimidazol con un 90% de tamano promedio menor que 450 nm y un surfactante polisorbato; metodo para su preparcion; metodo para preparar un medicamento; y uso para controlar infecciones parasitarias en animales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |